EpiPen maker’s stock value plunges nearly $3 billion as investors panic

‘Mylan Pharmaceuticals — the company that makes the EpiPen rescue device — has watched its stock value plummet over the last five days as panicky investors jump ship.
According to U.S. Uncut, outrage over Mylan’s decision to jack up the price of the EpiPen has spooked shareholders, whose departures have reduced the value of Mylan stock by 12.4 percent. On August 19, Mylan stocks went from $49.20 per share to $43.11 on August 24, a net loss of nearly $3 billion for the company.
The EpiPen is a popular rescue device for food allergy sufferers who run the risk of anaphylaxis — a potentially lethal reaction to allergen exposure. The device rapidly delivers a dose of epinephrine to the system, which for severe allergy sufferers can mean the difference between life and death.’
Read more: EpiPen maker’s stock value plunges nearly $3 billion as investors panic